Ask the Pharmacy – Are you getting the lowest cost for your PCSK9 inhibitor?
The manufacturers of both PCSK9 inhibitors, Praluent and Repatha, have lowered the list price for these cholesterol-lowering treatments by 60% to $5,850 per year. As we reported in February, the FH Foundation continues … Read More
Editor’s note: Today, Mike Smith shares how high cholesterol and heart disease took a toll on his family for generations. Until the day he had a proper diagnosis of familial hypercholesterolemia, and he knew he could manage it.
My story goes back longer than I can remember. I have a great … Read More
Familial Hypercholesterolemia can have devastating consequences – stealing people away from the people who love them. Today, we are honored to share this story from community member April Irene Donelson. April lost her fiancée to a sudden heart attack just months before they were to be married. … Read More